Question 1

What is Relay Therapeutics?

Accepted Answer

Relay Therapeutics is a Company.

Question 2

How often does Relay Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Relay Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 27, 2026.

Question 4

When was Relay Therapeutics last mentioned in news?

Accepted Answer

Last active on May 15, 2026.

Question 5

What is Relay Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Relay Therapeutics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Relay Therapeutics?

Accepted Answer

Relay Therapeutics Advances Zovegalisib to Phase 3 (Apr 27, 2026, 6 articles).

Question 8

How did the "Relay Therapeutics Advances Zovegalisib to Phase 3" event impact Relay Therapeutics?

Accepted Answer

Relay Therapeutics is advancing its drug zovegalisib into Phase 3 development for metastatic breast cancer, which could significantly boost its market position and revenue if approved.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.